title: Variable prolongation of cardiac allograft survival following intraportal administration of donor antigens.
authors.affiliation: Hepato-biliary Surgery and Liver Transplant Center, Paul Brousse Hospital, Villejuif, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Kise
authors.forename: O
authors.initials: O
authors.lastname: Farges
authors.forename: D
authors.initials: D
authors.lastname: Buffello
authors.forename: I
authors.initials: I
authors.lastname: Mansour
authors.forename: H
authors.initials: H
authors.lastname: Bismuth
mesh_terms: D000818:Animals; D006085:Graft Survival / Q000276:immunology*; D006680:HLA Antigens / Q000008:administration & dosage*; D016027:Heart Transplantation / Q000276:immunology*; D016130:Immunophenotyping; D016219:Immunotherapy, Adoptive; D007275:Injections, Intravenous; D007962:Leukocytes / Q000276:immunology*; D008297:Male; D011169:Portal Vein; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D014184:Transplantation, Homologous
chemical_list: D006680:HLA Antigens